Key result
Moderate-intensity exercise improves muscle strength, fatigue resistance, and capillarization in statin users and controls.
Why the study?
Does a 12-week moderate intensity endurance and resistance exercise training program improve muscle performance, mitochondrial function, and capillarization in symptomatic and asymptomatic statin users?
Does a 12-week moderate intensity endurance and resistance exercise training program improve muscle performance, mitochondrial function, and capillarization in symptomatic and asymptomatic statin users?
p-value: p=<0.001
Moderate intensity endurance and resistance exercise training safely improves muscle performance and capillarization in statin users without worsening statin-associated muscle symptoms, and improves quality of life in symptomatic users.
BACKGROUND The combination of statin therapy and physical activity reduces cardiovascular disease risk in patients with hyperlipidemia more than either treatment alone. However, mitochondrial dysfunction associated with statin treatment could attenuate training adaptations. OBJECTIVES This study determined whether moderate intensity exercise training improved muscle and exercise performance, muscle mitochondrial function, and fiber capillarization in symptomatic and asymptomatic statin users. METHODS Symptomatic (n = 16; age 64 ± 4 years) and asymptomatic statin users (n = 16; age 64 ± 4 years) and nonstatin using control subjects (n = 20; age 63 ± 5 years) completed a 12-week endurance and resistance exercise training program. Maximal exercise performance (peak oxygen consumption), muscle performance and muscle symptoms were determined before and after training. Muscle biopsies were collected to assess citrate synthase activity, adenosine triphosphate (ATP) production capacity, muscle fiber type distribution, fiber size, and capillarization. RESULTS Type I muscle fibers were less prevalent in symptomatic statin users than control subjects at baseline (P = 0.06). Exercise training improved muscle strength (P < 0.001), resistance to fatigue (P = 0.01), and muscle fiber capillarization (P < 0.01), with no differences between groups. Exercise training improved citrate synthase activity in the total group (P < 0.01), with asymptomatic statin users showing less improvement than control subjects (P = 0.02). Peak oxygen consumption, ATP production capacity, fiber size, and muscle symptoms remained unchanged in all groups following training. Quality-of-life scores improved only in symptomatic statin users following exercise training (P < 0.01). CONCLUSIONS A moderate intensity endurance and resistance exercise training program improves muscle performance, capillarization, and mitochondrial content in both asymptomatic and symptomatic statin users without exacerbating muscle complaints. Exercise training may even increase quality of life in symptomatic statin users. (The Effects of Cholesterol-Lowering Medication on Exercise Performance [STATEX]; NL5972/NTR6346).
No takes yet. Share an insight, caveat, or question.
Allard et al. (2021) studied Hyperlipidemia (statin users) (n=52). Moderate intensity endurance and resistance exercise training vs. Nonstatin using control subjects was evaluated on Maximal exercise performance, muscle performance, and muscle symptoms (p=<0.001). Moderate intensity exercise training improved muscle strength (P<0.001), resistance to fatigue (P=0.01), and capillarization (P<0.01) in symptomatic and asymptomatic statin users and controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: